Skip to content

Abstract 8653: Endothelial ADAM10 Preserves Fate Stability to Coordinate Collateral Remodeling and Cardiac Repair After Ischemic Injury

Nov 2026 · Circulation · 0 citations

Abstract

Background: Therapeutic angiogenesis remains an attractive strategy for Ischemic heart disease (IHD), yet clinical translation has been limited by the inability to generate durable and functional vascular networks. Increasing evidence suggests that successful vascular repair depends not only on endothelial activation but also on preservation of endothelial identity during remodeling. However, the molecular regulators governing this process remain poorly defined. Hypothesis: We hypothesized that ADAM10 supports EC identity maintenance during ischemic repair and that reduced ADAM10 is associated with impaired collateral formation, maladaptive fibrosis, and adverse cardiovascular outcomes. Methods: Plasma proteomics was performed in 148 patients with chronic total occlusion (CTO) and validated in an independent dual-center cohort of 712 CTO patients. Endothelial-specific Adam10 knockout mice ( Adam10 ΔEC ) were subjected to myocardial infarction (MI). Mechanisms were examined using single-cell RNA sequencing (scRNA-seq), lineage trajectory mapping, and intercellular crosstalk analysis of the cardiac ECs at serial time points after MI. Therapeutic potential of ADAM10 was evaluated using AAV-mediated gene delivery. Results: In patients, circulating ADAM10 was associated with coronary collateral circulation (CCC) and outcomes. ADAM10 discriminated favorable CCC formation with an ROC of 0.781. Low ADAM10 levels independently predicted major adverse cardiac and cerebrovascular events (MACCEs) (HR 0.772, 95% CI 0.666-0.895, P < 0.001), with significantly higher MACCE incidence observed in the low-ADAM10 group (30.0% vs 16.8%). In mice, endothelial-specific Adam10 knockout ( Adam10 ΔEC ) increased post-MI mortality (66.67% vs 17.65%) and impaired cardiac function (LVEF: 10.54% vs 56.00%, P = 0.001). and increased fibrosis (45.82% vs 14.53%, P < 0.001). scRNA-seq identified expansion of a mesenchymal-like endothelial population co-expressing endothelial and profibrotic genes, consistent with an EndoMT-like transition. ADAM10 deficiency promoted fibronectin-1-mediated fibroblast activation and maladaptive fibrotic remodeling. AAV-mediated ADAM10 expression improved cardiac function after MI (LVEF: 46.76% vs 9.60%, P < 0.001). Conclusions: ADAM10 acts as a key endothelial regulator during ischemic repair, supporting EC identity maintenance and limiting pathological profibrotic remodeling. Together, clinical and experimental findings suggest that endothelial competence, beyond endothelial proliferation alone, may be important for effective revascularization and cardiac recovery.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.